CMV retinitis: A simpler, oral treatment

Prescrire International

Volumn 12, Issue 66, 2003, Pages 133-135

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR; VALGANCICLOVIR; DRUG DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; DIARRHEA; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; DRUG TOLERABILITY; EDEMA; HUMAN; INFECTION; INFLAMMATION; NEUTROPENIA; RETINITIS; THROMBOCYTOPENIA; THRUSH; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG APPROVAL; DRUG SCREENING; EUROPEAN UNION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, ORAL; CLINICAL TRIALS; CYTOMEGALOVIRUS RETINITIS; DRUG APPROVAL; DRUG EVALUATION; EUROPEAN UNION; GANCICLOVIR; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0042011116     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Prescrire Rédaction "La rétinite par cytomégalovirus" Rev Prescr 2001; 21 (216): 262.
2. "Cytomegalovirus infection". In: Martindale "The Complete Drug Reference" 33rd ed, The Pharmaceutical Press, London 2002: 606-607.
3. Prescrire Editorial Staff "Ganciclovir and/or foscarnet? A difficult choice" Prescr Int 1998; 7 (37): 136.
4. Produits Roche "FDA Advisory Committee Briefing Document for valganciclovir Cl in the treatment of CMV retinitis in AIDS patients NDA 21-304" 22 January 2001: 91 pages.
5. College Ter Beoordeling von Geneesmiddelen-Medicine Evaluation Board - Public Assessment Report "valganciclovir" 16 January 2002: 21 pages.
6. Jung D and Dorr A "Single-dose pharmacokinetics of valganciclovir in HIV and CMV-seropositive subjects" J Clin Pharmacol 1999; 39: 800-804.
7. Brown F et al. "Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV-and CMV-seropositive volontears" Clin Pharmacokinet 1999; 37: 167-176.
8. Pescovitz MD et al. "Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients" Antimicrob Agents Chemother 2000; 44: 2811-2815.
9. Scholle C et al. "Pharmacokinetics of ganciclovir after prodrug valganciclovir in renal impairment" Kidney Blood Press Res 2000; 23: 333 (abstr.).
10. Agence Française de sécurité sanitaire des produits de santé "Rovalcyte°" 16 October 2002: 14 pages.
11. Martin DF et al "A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis" N Eng J Med 2002; 346: 1119-1126 + 347 (11): 862.
12. Lalezari J et al. "A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis" J Acquir Immune Defic Syndr 2002; 30 (4): 392-400.
13. Prescrire Editorial Staff "Cidofovir" Prescr Int 1998; 7 (37): 135-137.